Smith & Nephew PLC SN. StarRatingValueLabel_3

Last Price
782.50
Day Change
-2.50|-0.32%

As of 24/05/2013
16:44:21 BST | GBX  Minimum 15 Minutes Delay.

Bid/OfferDay RangeVolume90d Ave VolMkt Cap
0.00 - 0.00779.50 - 790.001,450,465- 7,087.799
Last Close52 Week RangeP/EYield %ISIN
785.00567.50 - 798.5014.151.66GB0009223206

Smith & Nephew Share Price

Morningstar's Take SN.

Smith & Nephew faces tough competitors in its chosen fields, but we think its devices offer compelling value propositions. The firm operates with two major segments: advanced surgical devices (a combination of the former orthopedic and endoscopy units) and advanced wound management.

Fair Value Estimate

720.00 GBX

Uncertainity

Average

Economic Moat

Narrow

Total Returns

 Chg (%)  
3yr, 5yr & 10yr performance data is annualised.
Smith & Nephew PLC4.61 
FTSE 100 TR GBP3.91
 
Financials
Annual
201020112012
more...
Income Statement
Turnover2,530.502,747.572,545.06
Operating Profit587.60554.66520.46
Net Profit392.80374.49448.48
Reported EPS44.2041.8349.77
Balance Sheet
Current Assets1,375.741,338.391,318.98
Non Current Assets1,647.191,635.672,151.95
Total Assets3,022.933,054.503,470.93
Current Liabilities583.76732.26572.13
Total Liabilities1,251.841,003.801,081.51
Total Equity1,771.092,050.712,389.42
Cash Flow
Cash From Operations709.59730.33728.39
Change in Net Cash9.58-21.231.23
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
more...
'Broker Forecasts' provides consensus figures based on several brokers' views
2013636.8349.93-9.6915.67-1.6217.372.22
2014697.4155.8211.8014.021.1919.202.45

Regulatory News

DateAuthor Headline
10/12/2012Alanna Petroff StanChart & Greggs Stand Out on FTSE
MONDAY MARKET UPDATE: Companies such as Standard Chartered and Greggs grabbed headlines in the UK, but overall, the FTSE was relatively flat on Monday
14/11/2011Julie Stralow, CFA Orthopaedic Device Makers Take a Step Back
Competitive advantages appear to be weakening, says Morningstar analyst Julie Stralow
04/10/2011Julie Stralow, CFA Government Spending and Orthopaedic Device Firms
Significant uncertainty about fiscal budgets and capital spending at hospitals leads us to place orthopaedic device firms under review
Director Dealings
TradedActionNotifierPriceAmountValue
more...
08/05/2013in Lieu of DividendSir John Buchanan759.852,24717,074.00
08/05/2013in Lieu of DividendOlivier Bohuon759.855113,883.00
02/04/2013SaleOlivier Bohuon763.0816,689127,350.00
02/04/2013Transfer inOlivier Bohuon0.0066,6670.00

Company Profile

Smith & Nephew PLC develops, manufactures, markets and sells medical devices in the sectors of Orthopaedics, Endoscopy and Advanced Wound Management. Its three operating segments are Orthopaedics, Endoscopy and Advanced Wound Management.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

10500

Outlook

(02/05/2013) "We see the outlook for the group as a whole for 2013 as unchanged from the view which we set out with our 2012 Full Year Results in February"

Next Event 02/08/2013

Next interim announcement
Ratios
 CompSecMkt
PER (E)14.9814.4113.95
Div Yld (E)2.312.273.75
PEG (E)-8.39-6.120.24
ROCE47.7838.173.67
Op Mrgn22.35-17.829.06
EPS Grwth-1.790.8916.04
Dividends
PreviousLatest
more...
Declared Date12/10/1219/04/13
Ex-Div10/10/1217/04/13
Paid30/10/1208/05/13
Amnt p6.3110.60

Broker Forecasts

Strong Buy0
Buy4
Hold3
Sell2
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
more...
Directors
more...
ChairmanSir John Buchanan
Chief Executive OfficerOlivier Bohuon
HelpGlossaryLicensing OpportunitiesData OpportunitiesCareersContact MorningstarAdvertiseSite Map
   
Make this site my homepage
© Copyright 2012 Morningstar. All rights reserved. Terms of Use | Privacy Policy | Cookies